000 01610 a2200433 4500
005 20250517211415.0
264 0 _c20180910
008 201809s 0 0 eng d
022 _a1420-3049
024 7 _a10.3390/molecules23040841
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGruber, Lisa
245 0 0 _aTreatment of Multidrug-Resistant Leukemia Cells by Novel Artemisinin-, Egonol-, and Thymoquinone-Derived Hybrid Compounds.
_h[electronic resource]
260 _bMolecules (Basel, Switzerland)
_cApr 2018
500 _aPublication Type: Journal Article
650 0 4 _aATP-Binding Cassette Transporters
_xmetabolism
650 0 4 _aAntineoplastic Agents
_xchemistry
650 0 4 _aArtemisinins
_xchemistry
650 0 4 _aBenzoquinones
_xchemistry
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aCell Survival
_xdrug effects
650 0 4 _aDoxorubicin
_xpharmacology
650 0 4 _aDrug Resistance, Multiple
_xdrug effects
650 0 4 _aDrug Resistance, Neoplasm
_xdrug effects
650 0 4 _aGene Expression Regulation, Neoplastic
_xdrug effects
650 0 4 _aHumans
650 0 4 _aLeukemia
_xdrug therapy
650 0 4 _aMolecular Docking Simulation
650 0 4 _aSuccinates
_xchemistry
700 1 _aAbdelfatah, Sara
700 1 _aFröhlich, Tony
700 1 _aReiter, Christoph
700 1 _aKlein, Volker
700 1 _aTsogoeva, Svetlana B
700 1 _aEfferth, Thomas
773 0 _tMolecules (Basel, Switzerland)
_gvol. 23
_gno. 4
856 4 0 _uhttps://doi.org/10.3390/molecules23040841
_zAvailable from publisher's website
999 _c28274678
_d28274678